Trial intelligence / Profile preview

Thalidomide in Patients With Mycobacterial and HIV Infections

NCT00004276Phase 2Completed

Sponsor
National Center for Research Resources
Start
Sep 1990
Modality
Small Molecules
01

Overview

A Phase 2 trial of thalidomide in human immunodeficiency virus infection (HIV), Tuberculosis (TB), sponsored by National Center for Research Resources. Started Sep 1990; status: completed.

02

Drugs

thalidomide
03

Conditions

human immunodeficiency virus infection (HIV)Tuberculosis (TB)

Beyond the preview

Go deeper on NCT00004276.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00004276.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call